Abbvie Inc at Wolfe Research Healthcare Conference (Virtual) Transcript
Hey, guys. I'm Timothy Anderson. I'm the large-cap pharma and biotech analyst at Wolfe Research. And we're at the start of our healthcare conference that runs today and tomorrow. We'll be talking with AbbVie next here for about the next 40 minutes or so, 3 members of the management team: Mike Severino, who's Vice Chairman and President, heads up R&D, among other things. He has been with the company since 2014. We have Rob Michael, who's EVP and CFO, he's been with the company since 2013; and Jeff Stewart, EVP of Commercial Operations, he's been with the company I think, since 1992, if I got that right; and Liz Shea is somewhere around there as well.
Questions & Answers
So I thought we'd start with some general questions here, and we'll have a wide-ranging discussion, but we'll see what we can get through. But first question, so 2021 coming to an end, 6 weeks left. How is the setup for 2022 looking for AbbVie? I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
